We have previously shown that prostaglandins of the A series are potent inhibitors of the replication of several animal viruses in cultured cells. In this report we have studied the mechanism of the antiviral action of PGA1 in vaccinia virus-infected mouse L cells, where there is an alteration in both the rate and extent of the synthesis of some virus proteins. When cytoplasmic RNAs from PGA-treated, vaccinia virus-infected cells were translated in cell-free systems, similar selective inhibition of the synthesis of some viral polypeptides was observed. The lack of translation of some viral RNAs was not due to an impairment of the methylation process nor to a difference in ionic requirements. PGA1, even at doses as high as 10 ~tg/ml, did not exert any direct inhibitory action on transcription in vitro as measured in two cell-free systems, and had no effect on primary transcription-translation of vaccinia virus RNAs when assayed in coupled cell-free systems. Southern blot hybridization analysis of cytoplasmic RNAs to EcoRI restriction fragments of vaccinia DNA showed that PGAa was able to induce major changes in the pattern of RNA transcripts during the course of viral infection. We propose that changes in the transcription programme of vaccinia virus RNAs could be due either to an alteration of specific viral proteins that regulate transcription by direct binding of PGAa, or to the synthesis and/or activation of a host product that mediates the antiviral action.
INTRODUCTION
Prostaglandins (PGs) are a group of naturally occurring cyclic 20-carbon fatty acids that are synthesized by most types of cells and have been shown to be involved in the control of a spectrum of physiological phenomena, including regulation of cell growth and differentiation (Jaffe & Santoro, 1977) , immune function (Goodwin & Webb, 1980) , interferon action (Stringfellow, 1978; Fitzpatrick & Stringfellow, 1980; Pottathil et al., 1980) and others. The possibility that some prostaglandins affect virus replication in cultured cells has recently been investigated. Harbour et al. (1978) have shown that prostaglandins of the E and F series increase the size of herpes simplex virus (HSV) plaques in Vero cells, while no effect was found on the production of some RNA viruses (measles virus and coxsackie virus B1). In contrast, inhibition of the production of parainfluenza 3 virus by PGE in Wish cells was reported by Luczak et al. (1975) .
In previous studies, we have demonstrated that pharmacological doses of prostaglandins of the A series potently inhibit replication of Sendai virus in African green monkey kidney cells (Santoro et al., 1980 (Santoro et al., , 1981 and of vaccinia virus in mouse L fibroblasts (Santoro et al., 1982a) . The antiviral effect was specific for prostaglandins of the A series (both PGA1 and Az) and dose-dependent. The most effective non-toxic dose, 4 ~tg/ml, produced 95"3~o inhibition of vaccinia virus replication, as measured by plaque titration on Vero cells. In uninfected L cells, ~ Present address: Institute of Cytomorphology of the C.N.R., S. Maria Imbaro (CH), Italy.
0022-1317/84/0000-5812 $02.00© 1984 SGM treatment with this dose of PGA1 for periods up to 24 h did not cause significant changes in the uptake of precursors and in the synthesis of DNA, RNA and proteins (Santoro et al., 1982a) . In vaccinia virus-infected L cells, the same dose of PGA1 did not alter the adsorption, penetration, or uncoating of the virus while it delayed and partially inhibited viral DNA synthesis. A further increase in the virus-induced 'shut-off' of protein synthesis was also shown (Santoro et al., 1982 a). While in uninfected cells there was no change in the pattern of the proteins synthesized, in vaccinia virus-infected cells, PGA1 produced a general change in the rate and extent of production of the viral polypeptides. Some viral proteins were not synthesized or appeared later, while other viral proteins were produced at the same rate as in control cells, suggesting that these changes were not due to a non-specific toxic effect but rather to a specific block in protein synthesis. This effect could be due to an inhibition of the transcription and/or the translation of viral RNAs. In order to determine at what level prostaglandins exert their inhibitory action, we have characterized, by translation in a cell-free system and by DNA-RNA hydridization analysis, the nature of viral RNAs synthesized in prostaglandin-treated cells. The data showed that PGAa was able to induce major changes in the pattern of RNA transcripts during the course of viral infection.
METHODS
Cell culture. Mouse L fibroblasts were grown in monolayer in Eagle's minimal essential medium (MEM) supplemented with 10~ newborn calf serum (NCS, Gibco), at 37 °C in a 5~ CO2 atmosphere.
Prostaglandins. PGA~ (Sigma) was stored as a 100~ ethanolic stock solution (10 mg/ml) at -20°C and was diluted to the appropriate concentration at the time of its use. Control media contained the same concentration of ethanol diluent (0.04~), which was shown not to affect cell metabolism. As determined by radioimmunoassay, PGA~ is stable in tissue culture medium for at least 24 h.
Virus. Vaccinia virus, strain WR, was grown in HeLa cells and purified according to the technique of Joklik (1962) . Confluent monolayers of cells were infected at an m.o.i, of 500 particles (10 p.f.u.) per cell for l h at 37 °C, after which time the virus inocula were removed and media containing 2~ NCS and PGA1 or ethanol diluent were added.
RNA extraction. RNA was isolated from vaccinia virus-infected or control L cells usually 4.5 h after infection (a time at which a complete pattern of synthesis of virus RNA and proteins was obtained), using a modification of the technique of Cabrera et al. (1978) . Cytoplasmic extracts were prepared by Dounce homogenization in 20 mMTris HCI pH 7.5, 3 mM-CaCI2, 3 mM-MgCI2, 0.5~ Nonidet P40, 10 mM-EDTA, and nuclei were removed by centrifugation (Esteban & Metz, 1973) . After addition of 0.4 M-NaC1 and 0-2 ~ SDS, supernatants were extracted as previously described ; nucleic acids were precipitated by the addition of 2 vol. ethanol for 12 h at -20 °C and resuspended in 200 vtl of 10 mM-Tris HC1 pH 7.6, 10 mM-MgC12. The RNA concentration was determined spectrophotometricaUy assuming 1 A260 unit is equivalent to 45 p.g RNA/ml. Generally, about 100 ~tg of RNA was recovered from 1 x 10 v cells. The RNA was essentially protein-free as determined by the Az6o/A28o ratio.
Cell-freeprotein synthesis. The message-dependent rabbit reticulocyte lysate used for these experiments has been previously described (Cooper & Moss, 1979) . Concentrations of cytoplasmic RNA ranging from 200 to 1000 ~tg/ml were used. [3sS]Methionine (Amersham) was added at a concentration of 10 p.Ci/25 ~tl sample. Samples were incubated at 30 °C for 60 rain and radioactive incorporation was measured by hot trichloroacetic acid (TCA) precipitation (Cooper & Moss, 1978) .
Polyacrylamide gel electrophoresis (PAGE) . Proteins labelled with [35S]methionine were analysed by SDS PAGE in a vertical slab gel apparatus, using the buffer system described by Laemmli (1970) . The 3 ~ stacking gel and 10 to 15~ resolving gradient gels were run at 120 V. The gels were washed, fixed in 10~ acetic acid, 10~ TCA and 30~ methanol, dried under vacuum and autoradiographed using DuPont Cronex films.
Hybridization of RNA to restriction fragments oJ vaccinia DNA. Purification of viral DNA, cleavage with the restriction endonuclease EcoRI, and analysis of the resulting fragments by electrophoresis in agarose gels have been previously described . DNA fragments separated in agarose gels were denatured in situ and transferred to nitrocellulose filters by a modification (McAllister & Barrett, 1977) of the method of Southern (1975) . Each filter strip received 1.5 to 1.7 p.g of viral DNA. Viral RNAs were labelled for 4 h, starting 30 rain after infection, with Na32po4 (Amersham) (1 mCi/2 x 107 cells) in the presence or absence of PGA~ (4 og/106 cells) and cycloheximide (100 ~tg/ml) (Flow Laboratories). After extraction, as described in the previous section, RNAs were resuspended in buffer (10 mM-Tris-HC1 pH 7-6, 10 mM-MgCI2), treated with 50 ~tg/ml DNase (Sigma) for 15 rain at 37 °C, re-extracted and precipitated with ethanol . Identical amounts of 32p-labelled RNA were added to nitrocellulose strips, with the exception that hydridization was carried out in the presence of 5 x SSC (1 × SSC = 0.15 M-NaC1, 0.015 M-sodium citrate), 0.1 ~o SDS, 10 mM-sodium phosphate and 50~ formamide. After 24 h at 42 °C, the filter strips were removed, rinsed repeatedly, and then incubated in 2 x SSC solution containing 20 ~g/ml pancreatic RNase (Sigma). Filter strips were autoradiographed using DuPont Cronex films.
Transcription in vitro by the vaccinia virion-associated RNA polymerase. Purified virions were collected by centrifugation and 2 × 101° virus particles were resuspended at 0 °C in 50 mM-Tris-HCl buffer pH 8.6, 6 mMMgClz, 7 mM-2-mercaptoethanol, 0-05~0 Nonidet P40, 3 mM-ATP, 1 mM-GTP and -CTP, 60 ~M-[3H]UTP (7.6 Ci/mmol) in a final volume of 0.4 ml (Kates & Beeson, 1970) . The reaction mixtures were sonicated for 10 s (50 W, Biosonik ultrasonicator) and incubated at 37 °C with continuous shaking in the presence of PGA~ or ethanol diluent. At appropriate intervals, aliquots were removed and the radioactive incorporation into hot TCAprecipitable material was determined (Cooper & Moss, 1978) .
Transcription ofvaccinia DNA with Escherichia coli RNA polymerase. The reaction mixtures (total volume of 100 ~tl) contained 80 ~tg/ml vaccinia virus DNA, 80 units/ml E. coli RNA polymerase (New England Nuclear) in 40 mM-Tris-HC1 buffer pH 7.9, 10 mM-MgC12, 0.1 mM-EDTA, 0-1 mM-DTT (dithiothreitol), 150 mM-KC1, 0.2 mM-ATP, -GTP, -CTP and 60 ~M-[3H]UTP. The reaction mixtures were incubated at 37 °C in the presence of PGA1 or ethanol diluent and, at various times, aliquots were removed and processed for counting of TCA-precipitable radioactive material (Cooper & Moss, 1978) .
Coupled transcription-translation cell-free system. Preparation of vaccinia virus cores and optimal conditions for the coupled cell-free system with rabbit reticulocytes were previously described (Cooper & Moss, 1978) . Prostaglandin or ethanol diluent were added at appropriate concentrations and incubation was carried out at 30 °C for 2 h. Samples were then dissolved and processed for SDS PAGE.
RESULTS

Effect of prostaglandin A 1 on a cell-free protein-synthesizing system
In order to determine whether PGA1 interferes directly with the translational machinery, viral mRNAs, isolated from vaccinia virus-infected cells 4-5 h after infection, were translated in a rabbit reticulocyte cell-free system in the presence of different doses (10 -3 to 10 ~tg/ml) of PGA1. Control assays received the same amounts of ethanol diluent. Fig. 1 (a) shows that none of the doses of PGA1 affected the rate of [3SS]methionine incorporation into TCA-precipitable material in this system. Different doses of ethanol were shown also not to influence protein synthesis. Moreover, when the polypeptides synthesized in this system were separated by SDS-PAGE (Fig. 1 b) , it was found that PGA1 did not produce any major change in the pattern of the proteins translated, even at doses as high as 10 ~tg/ml. In spite of the potent effect of PGA~ on protein synthesis in vaccinia virus-infected cells (Santoro et al., 1982a) , these results provided the evidence that PGA~ did not directly alter protein synthesis in vitro.
Characterization of viral RNAs produced in PGA-treated, vaccinia virus-infected cells
Since we were unable to identify a direct effect of PGA~ on RNA translation in vitro, we determined whether the inhibition of the synthesis of viral polypeptides that occurs in vivo could be related to changes in the synthesis and/or processing of viral mRNAs. Cytoplasmic RNAs were isolated from untreated and PGAl-treated (4 vtg/ml), uninfected or vaccinia virus-infected cells at 4-5 h after infection, and translated in a cell-free system as described in Methods. Fig.  2(a) shows that the rate of protein synthesis, measured as incorporation of [3SS]methionine in TCA-insoluble material was about threefold higher from RNAs isolated from vaccinia virusinfected cells than in RNAs derived from uninfected cells, as previously reported (Cooper & Moss, 1979) . PGA~ treatment did not cause any difference in the extent of translation of RNAs from uninfected cells but in infected cells, it produced a slight reduction (approx. 20~) of [35S]methionine incorporation (Fig. 2 a) . Fig. 2 (b) shows the PAGE analysis of the polypeptides translated in vitro. No significant changes in the synthesis of the polypeptides were noted when different concentrations of RNAs extracted from uninfected L cells (U), treated with PGA~ (+) or control diluent (-), were used. When RNAs extracted from vaccinia virus-infected cells were used, it was found that, while the general pattern of proteins synthesized was not altered, PGA1 treatment produced some minor changes in the synthesis of a number of virus proteins and dramatically inhibited the translation of at least three viral RNAs that code for polypeptides with molecular weights of about 38K, 20K and 14K, respectively (as indicated by arrows in Fig.  2b ). Even at concentrations of R N A as high as 1 mg/ml, these three polypeptides were not translated. This indicated that the m R N A s for these three proteins were either not present, or that they were structurally modified and consequently not translated. In order to establish whether the viral RNAs produced in vivo in the presence of PGA1 could be translated with efficiencies similar to those of R N A s from untreated cells, the effect of different concentrations of potassium ions on the translation of R N A s isolated from untreated and PGA-treated, infected cells was tested. Potassium ions were used in this experiment, since a study of the effect of different concentrations of Na + , Ca 2 +, Mg 2 + and K + has shown that the efficiency of vaccinia virus R N A translation is mainly influenced by changes in the concentration of this particular ion (results not shown). Even though R N A from PGA-treated, infected cells showed a slight reduction in the incorporation of [35S]methionine into acidinsoluble material, the optimal K + concentration required for protein synthesis was the same (120 to 140 mM) for both classes of R N A s (data not shown). To characterize the RNAs further and define whether PGA1 treatment induced changes in the methylation of R N A , in particular 'capping' at the 5' end, a similar set of experiments was carried out in the presence of S-adenosylhomocysteine (SAH), an inhibitor of R N A methylation (Banerjee, 1980) . In the presence of 200 gM-SAH, R N A s from PGA~-treated cells were similarly less effective messengers for protein synthesis (approx. 2 0~ decrease in [3sS]methionine incorporation), but there was no difference in the optimal K + concentration required (120 to 140 mM) for both classes of R N A . Moreover, we were unable to switch on the translation of the 38K, 20K and 14K polypeptides by changing ionic concentration in the presence or absence of SAH.
Effect of PGA1 on the transcription o f RNA in vaccinia virus-infected cells
The experiments described above suggest that some viral m R N A s may not be synthesized in PGA-treated, infected cells. In order to verify this hypothesis and to determine the relative abundance of vaccinia viral RNAs, Southern blot hybridization analysis was performed. After a period of 30 min of virus adsorption, RNAs were labelled with 32po 4 in the presence or absence of PGA1 (4 ~tg/ml). 32p-labelled cytoplasmic R N A s were extracted 4 h later. Early RNAs were obtained by blocking protein synthesis with the addition of 100 ~tg/ml cycloheximide during the labelling period. Fig. 3 shows the pattern of hybridization of'early' and 'early + late' classes of viral RNAs to EcoRI restriction fragments of vaccinia DNA, separated by electrophoresis on agarose gel. Although PGA1 did not seem to alter transcription of early RNAs, some major differences were observed in the hybridization to individual restriction fragments when late R N A s from untreated and PGA-treated, infected cells were compared. Whereas some late RNAs were found to hybridize to a similar extent, PGA1 altered the transcription of other late mRNAs, sometimes decreasing, and sometimes increasing their synthesis, when compared to late RNAs from untreated cells. Moreover, after PGA treatment, at least one RNA band was not present (moL wt. 1.9 x l06, arrow), and some early RNAs were still synthesized at late times (mol. wt. 2.8 × 10 6 and 1-3 x 10 6, dots), a result consistent with the fact that some early viral proteins are synthesized at a late time post-infection in PGA-treated cells (Santoro et al., 1982a) . This differential effect of PGA1 between early and late viral RNAs might suggest a direct action of PGA1 (possibly by its binding and altering their structure) on some early viral products that regulate the switch-on of later viral genes. However, the possibility that the presence of cycloheximide could inhibit PGA action in vitro should also be considered. Alternatively, PGA1 could interfere directly with the transcriptional programme of vaccinia virus.
Effect of PGA 1 on transcription of viral mRNA in vitro In order to establish whether PGA~ has a direct effect on the transcription of viral RNAs, we tested the effect of different doses of PGA1 on two in vitro transcription systems, using either the vaccinia virion-associated DNA-dependent RNA polymerase or E. coli RNA polymerase holoenzyme. Fig. 4 shows the time course of [3H]UTP incorporation into acid-insoluble material with both systems, in the presence and absence of 4 ~tg/ml PGA1. PGA~ treatment did not significantly alter the rate of RNA transcription in vitro with either polymerase, thus excluding the possibility that PGA~ directly interferes with the transcription process. Agarose gel electrophoretic analysis showed that the same sizes of RNAs were produced under each set of conditions (data not shown). Further evidence that PGA~ does not directly modify viral transcription was obtained in a coupled transcription and translation cell-free system programmed with vaccinia virus cores. Fig. 5 shows that PGAa did not change either the rate or pattern of transcription and translation of vaccinia RNAs as determined by kinetic studies and by PAGE analysis of the proteins synthesized in vitro.
DISCUSSION
In this study we have investigated the mechanism of the antiviral action of prostaglandins of the A series in mouse L cells infected with vaccinia virus. Even though very little is known about the molecular basis of the action of prostaglandins, it has been shown that PGs can control ion transport across cell membranes (Lafferty et al., 1972) , stimulate cyclic AMP (cAMP) synthesis in cells of different origin (Kuehl, 1974) , and trigger synthesis de novo of a cellular protein (Santoro et al., 1982b) . The possibility that changes in the ionic environment of the host cell could influence transcription was excluded after examining cell-free translation of viral R N A in the presence of different concentrations of potassium ions.
The fact that c A M P has an effect opposite to that of PGA1, enhancing the translation of vaccinia m R N A in a cell-free system through inactivation of the double-stranded R N A form (Legon et al., 1974) , and that c A M P does not alter the pattern of proteins synthesized in this system (unpublished results), suggests that the PGA1 action is not mediated by cAMP. In this report, we have shown that PGA1 is able to induce major changes in the pattern of R N A transcripts during the course of vaccinia virus infection in L cells and that the previously reported lack of synthesis of some viral polypeptides (Santoro et al., 1982a) in PGA-treated cells correlates with the inhibition of the synthesis of some viral m R N A . These findings were confirmed both by translation in a cell-flee system using viral R N A and by Southern blot hybridization of isolated cytoplasmic RNAs, with E c o R I restriction fragments of purified vaccinia D N A . The fact that the majority of the viral R N A s were transcribed and translated with similar efficiencies in both untreated and PGA-treated cells suggests that PGA1 affects the transcription of some specific viral genes. Since it has been shown (Moss, 1974) that changes in the programmed sequence of events (synthesis of immediate early, early, and then late viral RNA and proteins) in vaccinia virus replication cause inhibition of virus production, we believe that the changes in the synthesis of RNAs and proteins of vaccinia virus, described in this study, may be responsible for the antiviral action of PGA1.
In conclusion, we have shown for the first time that a prostaglandin can influence the control of gene expression. Since we could not demonstrate a direct effect of PGA1 on transcription in cell-free transcribing systems in vitro, the possibility remains that PGAI acts through an indirect mechanism. This might be related either to alterations in the host cell, which in turn modify the pattern of viral transcription, or to alterations of the structure and/or function of viral products, which are involved in the switch-on of other viral genes.
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